These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2529858)

  • 21. Renal and vascular effects of atrial natriuretic factor during cardiopulmonary bypass.
    Hynynen M; Palojoki R; Heinonen J; Tikkanen I; Harjula AL; Fyhrquist F
    Chest; 1991 Nov; 100(5):1203-9. PubMed ID: 1834440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of the natriuretic effects of neutral endopeptidase inhibition in Dahl salt-sensitive and salt-resistant rats.
    Hirata Y; Suzuki E; Hayakawa H; Matsuoka H; Sugimoto T; Kangawa K; Matsuo H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):283-90. PubMed ID: 7511759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal dopamine not renal nerve mediates diuretic and natriuretic effect of ANF in rats.
    Kau MM; Huang WC
    Chin J Physiol; 1991; 34(3):317-31. PubMed ID: 1839729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociation of natriuresis and diuresis and heterogeneity of the effector system of atrial natriuretic factor in rats.
    Willenbrock RC; Tremblay J; Garcia R; Hamet P
    J Clin Invest; 1989 Feb; 83(2):482-9. PubMed ID: 2536399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
    Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
    Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure.
    Seymour AA; Asaad MM; Lanoce VM; Fennell SA; Cheung HS; Rogers WL
    Cardiovasc Res; 1993 Jun; 27(6):1015-23. PubMed ID: 8221758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged inhibition of endopeptidase 24.11 in normal man: renal, endocrine and haemodynamic effects.
    Richards AM; Wittert G; Espiner EA; Yandle TG; Frampton C; Ikram H
    J Hypertens; 1991 Oct; 9(10):955-62. PubMed ID: 1658138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of ANF and urodilatin during cANF receptor blockade and neutral endopeptidase inhibition.
    Abassi ZA; Tate J; Hunsberger S; Klein H; Trachewsky D; Keiser HR
    Am J Physiol; 1992 Nov; 263(5 Pt 1):E870-6. PubMed ID: 1443119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency].
    Varin J; Duboc D; Weber S; Fouchard J; Schwartz JC; Muffat-Joly M; Guérin F
    Arch Mal Coeur Vaiss; 1991 Oct; 84(10):1465-71. PubMed ID: 1662033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
    Richards AM; Crozier IG; Espiner EA; Ikram H; Yandle TG; Kosoglou T; Rallings M; Frampton C
    J Cardiovasc Pharmacol; 1992; 20(5):735-41. PubMed ID: 1280735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors.
    Seymour AA; Norman JA; Asaad MM; Fennell SA; Abboa-Offei B; Little DK; Kratunis VJ; Delaney NG; Hunt JT; Di Donato G
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1002-9. PubMed ID: 1826031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors of ANF metabolism. Potential therapeutic agents in cardiovascular disease.
    Granger JP
    Circulation; 1990 Jul; 82(1):313-5. PubMed ID: 2142024
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of UK-79,300, an orally-absorbed atriopeptidase inhibitor, in a conscious dog model of cardiac insufficiency.
    Alabaster CT; Machin I; Samuels GM; Sutton MR
    Br J Pharmacol; 1989 Dec; 98 Suppl():823P. PubMed ID: 2611529
    [No Abstract]   [Full Text] [Related]  

  • 34. The character of the atrial natriuretic response: pressure and volume effects.
    Blaine EH; Heinel LA; Schorn TW; Marsh EA; Whinnery MA
    J Hypertens Suppl; 1986 Jun; 4(2):S17-24. PubMed ID: 2941539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute hypocapnia blunts natriuretic and diuretic effects of atrial natriuretic factor in rats.
    Mimura Y; Khraibi AA; Heublein DM; Knox FG
    Am J Physiol; 1994 May; 266(5 Pt 2):R1503-9. PubMed ID: 8203627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three peptides from the ANF prohormone NH(2)-terminus are natriuretic and/or kaliuretic.
    Martin DR; Pevahouse JB; Trigg DJ; Vesely DL; Buerkert JE
    Am J Physiol; 1990 May; 258(5 Pt 2):F1401-8. PubMed ID: 2140017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutral endopeptidase inhibition potentiates the natriuretic actions of adrenomedullin.
    Lisy O; Jougasaki M; Schirger JA; Chen HH; Barclay PT; Burnett JC
    Am J Physiol; 1998 Sep; 275(3):F410-4. PubMed ID: 9729514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of cyclophosphamide on arginine vasopressin and the atrial natriuretic factor.
    Larose P; Ong H; du Souich P
    Biochem Biophys Res Commun; 1987 Feb; 143(1):140-4. PubMed ID: 2950859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of renal nerves in the hypotensive and the renal effects of atrial natriuretic factor in rats.
    Kau MM; Wu JN; Huang WC
    Chin J Physiol; 1990; 33(1):5-18. PubMed ID: 2142916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of endopeptidase-24.11 inhibition and of atrial natriuretic peptide clearance receptor ligand on the response to rat brain natriuretic peptide in the conscious rat.
    Kirk JE; Wilkins MR
    Br J Pharmacol; 1993 Sep; 110(1):350-4. PubMed ID: 8220896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.